Delivery Order SPE2DB22D2211-SPE2DB25FRYUD

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,139.26 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Refresh Plus 0.5% eye drops in 30-count packages, with a completion date of June 5, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a $1,687.78 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Refresh Plus 0.5% eye drops in 30-count packages, with a performance period ending on May 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is also the holder of a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a $1,595.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S", a type of prescription eye drops. The contract has a completion date of July 18, 2024 and does not utilize a set-aside designation. As a leading supplier of pharmaceutical and medical products to the federal government, AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for $14,602.73. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a medical product, on a firm fixed price basis. The contract has a period of performance through May 31, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,133.13, is for the supply of Refresh Plus 0.5% eye drops. The contract has an ultimate completion date of April 16, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,174.72, is for the provision of REFRESH PLUS 0.5% EYE DROPS 30S, a medical supply product. The contract has a period of performance through March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This $1,093.42 firm fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4,561,837,935 units of REFRESH PLUS 0.5% EYE DROPS UD 50S, a prescription ophthalmic product, with a period of performance ending on August 18, 2023. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S." The contract has a ceiling value of $3,097.72 and a period of performance through July 19, 2024. The contract is a firm-fixed-price, non-set-aside award. Amerisourcebergen, through its Corporate Office division, is responsible for delivering the requested eye drops to support federal...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,857.20 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S," a pharmaceutical product, with a period of performance through May 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Plus 0.5% eye drops. The contract has a ceiling value of $1,206.20 and an ultimate completion date of August 1, 2024. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen, through its extensive supply chain and distribution network, will provide these medical supplies to support military treatment...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRYUD
    Delivery Order

This is a $2,261.62 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Refresh Plus 0.5% eye drops in 30-count packages, with a period of performance through June 2025. The contract is not set aside and was awarded through open competition. AmerisourceBergen is a critical vendor supporting the DLA's medical procurement needs, particularly for military and veteran healthcare systems, through a $999,999,999.00 Indefinite Delivery Contract (IDC) that provides a comprehensive global pharmaceutical support vehicle.

Generated 9/9/25, 12:46 PM